Patent details
EP1854477 Title: Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
Basic Information
- Publication number:
- EP1854477
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP070051826
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
- French Title of Invention:
- Compositions et procédé de traitement de troubles ophtalmiques
- German Title of Invention:
- Zusammensetzungen und Verfahren zur Behandlung von Augenerkrankungen
- SPC Number:
Dates
- Filing date:
- 13/03/2007
- Grant date:
- 03/08/2016
- EP Publication Date:
- 03/08/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/11/2007
- EP B1 Publication Date:
- 03/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 13/03/2027
- Renunciation date:
- Revocation date:
- 15/11/2022
- Annulment date:
Owner
- From:
- 21/06/2021
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
History of Owners
- From:
- 13/03/2007
- To:
- 21/06/2021
- Name:
- Dyax Corp.
- Address:
- 55 Network Drive, Burlington, MA 01803, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 25/10/2016
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
- Name:
- Belichard Pierre
- Address:
- France (FR)
Priority
1
- Priority Number:
- 06360008
- Priority Date:
- 16/03/2006
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 06291516
- Priority Date:
- 26/09/2006
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 38/55;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2021/08
- Publication date:
- 01/07/2021
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2023/06
- Publication date:
- 05/05/2023
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 201811
- Publication date:
- 14/03/2018
- Description:
- Document reprinted after correction (B8, B9)
2
- Issue number:
- 201847
- Publication date:
- 21/11/2018
- Description:
- Title of invention Modified
3
- Issue number:
- 202315
- Publication date:
- 12/04/2023
- Description:
- Revocation of the European patent
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20210000252A
- Date Registered:
- 21/06/2021
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Baker & McKenzie
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 21/02/2023
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 22/06/2021 | Outgoing Correspondence | 2 |
| 21/06/2021 | Request For Change | 6 |